Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
Change of CD20 expression was examined in cases of diffuse large B-cell lymphoma (DLBCL). CD20 expression after treatment with anti-CD20 antibody (rituximab, Rx) for DLBCL was examined in 23 cases who received serial biopsy by immunohistochemistry (IHC) and flow cytometry (FCM). CD20– by IHC and/or...
Full description
Bibliographic Details
| Main Authors: |
Naoki Wada,
Masaharu Kohara,
Hiroyasu Ogawa,
Haruo Sugiyama,
Shirou Fukuhara,
Yoichi Tatsumi,
Akihisa Kanamaru,
Masayuki Hino,
Yuzuru Kanakura,
Eiichi Morii,
Katsuyuki Aozasa |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Karger Publishers
2009-10-01
|
|---|
| Series: | Case Reports in Oncology
|
|---|
| Subjects: | |
|---|
| Online Access: | http://www.karger.com/Article/FullText/249152
|
|---|